Kala制药(KALA)

3.61 -0.17 -4.4974%

今开:3.76昨收:3.78
最高:3.8 最低:3.55
涨停价:0.0跌停价:0.0
总市值:2.33358938E8

Kala制药的热门评论

Kala制药(KALA)2019-05-10 09:45

$Kala制药(KALA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-09 AccNo: 0001558370-19-004703 Size: 5 MB 网页链接查看全文

Kala制药(KALA)2019-05-09 23:10

$Kala制药(KALA)$ 8-K - Current report Filed: 2019-05-09 AccNo: 0001558370-19-004563 Size: 252 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Kala制药(KALA)2019-05-06 18:35

$Kala制药(KALA)$ 美东时间 2019-05-09 盘前 披露财报,预期EPS -0.81 网页链接查看全文

Kala制药(KALA)2019-04-13 10:40

$Kala制药(KALA)$ DEF 14A - Other definitive proxy statements Filed: 2019-04-12 AccNo: 0001558370-19-002956 Size: 991 KB 网页链接查看全文

Kala制药(KALA)2019-04-13 10:40

$Kala制药(KALA)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-04-12 AccNo: 0001558370-19-002961 Size: 194 KB 网页链接查看全文

Kala制药(KALA)2019-03-12 10:40

$Kala制药(KALA)$ 8-K - Current report Filed: 2019-03-11 AccNo: 0001558370-19-001781 Size: 278 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Kala制药(KALA)2019-03-12 22:50

$Kala制药(KALA)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-12 AccNo: 0001558370-19-001825 Size: 11 MB 网页链接查看全文

Kala制药(KALA)2019-03-12 22:50

$Kala制药(KALA)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-03-12 AccNo: 0001558370-19-001827 Size: 161 KB 网页链接查看全文

Kala制药(KALA)2019-03-06 19:35

$Kala制药(KALA)$ 美东时间 2019-03-11 盘后 披露财报,预期EPS -0.52 网页链接查看全文

Kala制药(KALA)2019-02-14 11:05

$Kala制药(KALA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-13 AccNo: 0001193125-19-037954 Size: 137 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Kala制药的最新评论

Takeabreak07-22 11:50

$Karyopharm(KPTI)$ $G1治疗(GTHX)$ $Kala制药(KALA)$ BTAI. Value destroyers?? Commercialization is more risky. Lesson learned??? Or patience is a virtue ??查看全文

Spica07-18 19:54

回复@Takeabreak: 我问了下一位做干眼症的朋友,他是这么回复的“”Eysuvis 应该还不错,但不会成为重磅。重要的原因:lotemax一直被off label用作治疗干眼,$Kala制药(KALA)$ 只是改了一个剂型,把off label变成approved。Lotemax医生可以随便开的,会一定程度限制了Eysuvis销售“//@Takeabreak:...查看全文

Kala制药(KALA)07-01 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-29,CHIEF SCIENTIFIC OFFICER,Chen Hongming ,卖出,5548普通股, $5.56查看全文

持股变动声明

Kala制药(KALA)07-01 05:36

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-003271 Size: 5 KB 网页链接查看全文

Kala制药(KALA)06-30 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF EXECUTIVE OFFICER,Iwicki Mark T ,卖出,7586普通股, $5.77查看全文

Kala制药(KALA)06-30 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF FINANCIAL OFFICER,Reumuth Mary ,卖出,2452普通股, $5.77查看全文

Kala制药(KALA)06-30 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-28,SEE REMARKS,Trachtenberg Eric ,卖出,2452普通股, $5.77查看全文

Kala制药(KALA)06-30 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF SCIENTIFIC OFFICER,Chen Hongming ,卖出,2452普通股, $5.77查看全文

Kala制药(KALA)06-30 07:33

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF MEDICAL OFFICER,Brazzell Romulus K ,卖出,3034普通股, $5.77查看全文

持股变动声明

Kala制药(KALA)06-30 05:42

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-003256 Size: 4 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Kala制药的公告

$Kala制药(KALA)$ 内部交易: 2021-06-29,CHIEF SCIENTIFIC OFFICER,Chen Hongming ,卖出,5548普通股, $5.56

持股变动声明

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-003271 Size: 5 KB 网页链接

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF EXECUTIVE OFFICER,Iwicki Mark T ,卖出,7586普通股, $5.77

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF FINANCIAL OFFICER,Reumuth Mary ,卖出,2452普通股, $5.77

$Kala制药(KALA)$ 内部交易: 2021-06-28,SEE REMARKS,Trachtenberg Eric ,卖出,2452普通股, $5.77

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF MEDICAL OFFICER,Brazzell Romulus K ,卖出,3034普通股, $5.77

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF SCIENTIFIC OFFICER,Chen Hongming ,卖出,2452普通股, $5.77

持股变动声明

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-003256 Size: 4 KB 网页链接

持股变动声明

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-003257 Size: 5 KB 网页链接

持股变动声明

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-003259 Size: 4 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24